Efficacy of Stenorol (halofuginone). II. Plus roxarsone or bacitracin MD against selected strains of chicken Eimeria.
A total of 879 broiler strain chickens ranging from 2 1/2- to 7 1/2 weeks of age was utilized in four battery experiments to determine whether Roxarsone and/or bacitracin MD added to halofuginone were compatible and beneficial in reducing the effects of coccidial infections. The additives were generally beneficial as measured by weight gain and feed efficiency but not as measured by other parameters such as dropping score, lesion score, or oocyst production. The addition of 200 g of bacitracin/ton of feed did not give an additional response above that from 50 g/ton. Roxarsone in the ration was more effective in younger chickens (2 1/2 week old) than older ones (6 weeks, 2 days and 7 weeks, 3 days).
D000818:Animals; D001152:Arsenicals / Q000627:therapeutic use*; D001414:Bacitracin / Q000627:therapeutic use*; D001835:Body Weight; D002645:Chickens / Q000469:parasitology; D003048:Coccidiosis / Q000188:drug therapy*; D003049:Coccidiostats / Q000627:therapeutic use*; D004338:Drug Combinations; D004539:Eimeria / Q000187:drug effects; D005247:Feeding Behavior / Q000187:drug effects; D010880:Piperidines / Q000627:therapeutic use; D011201:Poultry Diseases / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*; D052999:Quinazolinones; D012406:Roxarsone / Q000627:therapeutic use*; D012459:Salicylates / Q000627:therapeutic use*
D001152:Arsenicals; D003049:Coccidiostats; D004338:Drug Combinations; D010880:Piperidines; D011799:Quinazolines; D052999:Quinazolinones; D012459:Salicylates; D001414:Bacitracin; D012406:Roxarsone; C023400:bacitracin methylenedisalicylic acid; C010176:halofuginone